After a significant increase in 2023, Danish regions' expenses for subsidized medicines fell by 4.3% in 2024.

US CNS-focused biopharma firm Axsome Therapeutics today announced that the EMERGE Phase III trial of Symbravo (MoSEIC ...

US pharma giant Pfizer has ended all development and commercialization activities relating to fidanacogene elaparvovec, a ...

One of the USA’s largest compounders, Hims & Hers, has announced the acquisition of a peptide facility in California.

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

Mitsubishi Tanabe Pharma (MTPC) today announced that the European Medicines Agency (EMA) has accepted for review the ...

Spanish dermatology company Almirall was trading 4% higher on Monday afternoon after presenting its full-year 2024 financial ...

Earlier this month, the Norwegian government launched the cancer strategy Joint Efforts Against Cancer, with five national ...

Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...

Japanese drug major Shionogi announced that Jeil Pharmaceutical, its partner in South Korea, has obtained marketing approval ...

The US Food and Drug Administration (FDA) late Friday revealed it has approved Ctexli (chenodiol) for the treatment of ...

Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...